Beijing SL Pharmaceutical Co., Ltd.

002038

CNE000001L31

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
8.61 ^CNY	+2.74%		+3.61%	-15.51%

Apr. 24	Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	CI
Apr. 23	Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Beijing SL Pharmaceutical Co., Ltd. Implements Final Dividend on Share A for 2021, Payable on June 29, 2022

June 22, 2022 at 03:37 pm EDT

Beijing SL Pharmaceutical Co., Ltd. implemented Cash dividend/10 shares (tax included): CNY 1.00000000 on share A for 2021. Record date: 28 June 2022, Ex-date: 29 June 2022 and Payable on June 29, 2022.

Latest news about Beijing SL Pharmaceutical Co., Ltd.

Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	Apr. 23	CI
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Chinese Shares Extend Losses on Middle East Conflict; Beijing SL Pharmaceutical Slumps Despite Drug Trial Approval	23-10-20	MT
Beijing SL Pharmaceutical Gets Nod to Trial Anti-Hepatitis C Drug; Shares Drop 10%	23-10-20	MT
Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs	23-10-17	MT
Beijing SL Pharmaceutical Gets Certificate for PEGylated Human Granulocyte Stimulating Factor Injection; Shares Up 3%	23-09-25	MT
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Beijing SL Pharma Gets Registration Certificate for Cancer Drug	23-06-20	MT
Beijing SL Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 28 June 2023	23-05-26	CI
Beijing Sl Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	23-04-26	CI
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Beijing SL Pharma Registers Diabetes Drug	23-03-23	MT
Beijing SL Pharmaceutical's Flu Medicine Gets Marketing Nod in China	22-12-23	MT
Beijing SL Pharmaceutical Gets Regulatory Approval for Argatroban Injection	22-11-08	MT
Beijing SL Pharmaceutical Co., Ltd. agreed to acquire remaining 30% stake in Xinxiang SL Pharmaceutical Co., Ltd. from Xinxiang Chemical Fiber Co., Ltd. for CNY 10.8 million.	22-10-30	CI
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
Beijing SL Pharmaceutical Co., Ltd. Implements Final Dividend on Share A for 2021, Payable on June 29, 2022	22-06-22	CI
Beijing SL Pharmaceutical Co., Ltd.(SZSE:002038) dropped from Shenzhen Stock Exchange Component A Share Index	22-06-10	CI
Beijing SL Pharmaceutical Co., Ltd.(SZSE:002038) dropped from Shenzhen Stock Exchange Component Index	22-06-10	CI
Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-27	CI
Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2021	22-04-26	CI
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI

Chart Beijing SL Pharmaceutical Co., Ltd.

Duration

Period

Chart Beijing SL Pharmaceutical Co., Ltd.

More charts

Company Profile

Beijing SL Pharmaceutical Co., Ltd. specializes in manufacturing and marketing medicines produced by genetic engineering. Products are primarily for treating neutropenia, thrombocytopenia, renal cancer, melanoma and chronic skin ulcer.

Sector

Pharmaceuticals

Calendar

2024-05-23 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

8.61 CNY

Average target price

12 CNY

Spread / Average Target

+39.37%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING SL PHARMACEUTICAL CO., LTD.	-15.51%	1.19B
ELI LILLY AND COMPANY	+26.47%	661B
NOVO NORDISK A/S	+26.74%	566B
JOHNSON & JOHNSON	-6.33%	352B
MERCK & CO., INC.	+19.35%	332B
ABBVIE INC.	+4.23%	283B
ASTRAZENECA PLC	+13.43%	231B
NOVARTIS AG	+4.71%	200B
ROCHE HOLDING AG	-9.53%	195B
AMGEN INC.	-4.04%	145B

Other Pharmaceuticals